Delirium Identification in Older Patients With Alzheimer's and Other Related Dementias In the Emergency Department
Launched by OHIO STATE UNIVERSITY · Mar 21, 2024
Trial Information
Current as of October 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to better identify delirium in older patients who have Alzheimer's disease or other types of dementia while they are in the Emergency Department. Delirium is a serious condition that can make patients confused and can lead to worse health outcomes, especially for those with dementia. The researchers want to see if using wrist sensors to monitor things like heart rate and movement can help doctors detect delirium more accurately than the current methods, which often miss it.
To participate in this trial, you need to be at least 65 years old and have a diagnosis of dementia, or your doctors should suspect that you have it. You also need to be visiting the Emergency Department and expect to stay for more than four hours. However, if you are on a ventilator, undergoing sedation for a procedure, or unable to provide consent without a caregiver present, you won't be eligible. If you join the study, you can expect to wear a wrist sensor during your hospital visit, which will help researchers learn more about how to improve delirium detection in older adults with dementia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adults patients 65+ years old with a known diagnosis of dementia or medical team highly suspects or confirms dementia this visit.
- • Emergency Department visit and/or hospitalization anticipated to last \>4 more hours from the time of enrollment.
- Exclusion Criteria:
- • Intubation/mechanical ventilation
- • Patients undergoing a procedure requiring sedation
- • Patients who cannot consent due to cognitive impairment and do not have a legally authorized representative or caregiver present.
About Ohio State University
The Ohio State University (OSU) is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a commitment to improving patient care and outcomes, OSU leverages its extensive resources, interdisciplinary collaboration, and expertise in diverse medical fields. The university fosters an environment of rigorous scientific inquiry, ensuring that clinical trials are conducted with the highest ethical standards and adherence to regulatory guidelines. Through its Clinical Trials Office, OSU aims to translate groundbreaking research into practical applications, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Patients applied
Trial Officials
Edward Boyer, MD
Study Director
Ohio State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported